Roivant Sciences (ROIV) Non-Current Debt (2021 - 2024)

Roivant Sciences has reported Non-Current Debt for 4 years, with the latest figure at $191.5 million in Q2 2024.

• For the quarter ending Q2 2024, Non-Current Debt rose 440.38% year-over-year to $191.5 million; the trailing twelve-month figure through Jun 2024 stood at $191.5 million (up 440.38% YoY), and the FY2024 full-year result was $37.5 million, down 76.57% from the prior year.
• Non-Current Debt for Q2 2024 stood at $191.5 million, up from $37.5 million in the prior quarter.
• The five-year high for Non-Current Debt was $204.0 million in Q4 2021, with the low at $32.6 million in Q1 2022.
• Historically, Non-Current Debt has averaged $124.8 million across 4 years, with a median of $164.4 million in 2023.
• Annual changes were most pronounced in 2022 — Non-Current Debt slumped 83.22% — and 2024, when it surged 440.38%.
• Roivant Sciences' Non-Current Debt stood at $204.0 million in 2021, then sank by 83.22% to $34.2 million in 2022, then soared by 402.21% to $172.0 million in 2023, then gained by 11.36% to $191.5 million in 2024.
• The last three Non-Current Debt figures came in at $191.5 million (Q2 2024), $37.5 million (Q1 2024), and $172.0 million (Q4 2023), per Business Quant data.